Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesAkanda Corp

Akanda Corp

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.811 USD -0.03 ( 3.46%)
Last update at 2026-11-09T15:06:00Z
VOLUME
27416
Market Cap
1.74M

Momentum Score

…

As of August 21, 2025, Akanda Corp. was acquired by First Towers & Fiber Corp., in a reverse merger transaction. Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products. The company was incorporated in 2021 and is headquartered in Toronto, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.79
Low
0.82
High
52 Week Price Range
2.30
Low
121.06
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Akanda Corp (AKAN) has limited public disclosures and its publicly available filings do not clearly describe an operating business. Because of that, long-term growth drivers and investor attractions cannot be reliably assessed; investors should consult SEC filings and company releases. The company could appear attractive if it later documents a scalable business model or clear revenue visibility, but such prospects are not evident in current public information.

Primary investment risk is limited disclosure, which raises information and liquidity risk and creates execution and financing uncertainty.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.84
Dividend Yield
-
Revenue TTM
0.84M
Revenue Per Share
31.12
Gross Profit TTM
0.21M
Debt / Equity
0.08
ROE
-60.86%
Net Debt
-3.49M
ROCE
-74.09%
Diluted EPS TTM
696.80

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -3.27M -32.28M -8.24M -8.13M -2.30M
Net income -4.10M -32.28M 0.40M -9.22M -2.95M
Selling general administrative 4.45M 5.88M 19.85M 5.81M 1.36M
Selling and marketing expenses - 2.40M - - -
Gross profit 0.21M 0.11M 3.27M -0.71M 0.00M
Reconciled depreciation 0.14M 4.28M 3.76M 0.31M 0.25M
Ebit -3.17M -32.02M -20.18M -6.83M -1.67M
Ebitda -3.03M -27.74M -16.41M -6.50M -1.41M
Depreciation and amortization 0.14M 4.28M 3.76M 0.34M 0.26M
Operating income -4.38M -10.05M -20.18M -6.83M -1.67M
Other operating expenses 5.22M 12.21M 22.80M 6.88M 1.67M
Interest expense 0.10M 0.26M 0.12M 1.09M 0.65M
Interest income 0.01M 0.00M 0.00M 0.03M 0.01M
Net interest income -0.09M -0.26M -0.11M -1.07M -0.63M
Income tax expense - -0.00M -8.63M 1.09M 0.65M
Total revenue 0.84M 2.16M 2.62M 0.04M 0.00M
Total operating expenses 4.59M 10.16M 23.45M 6.12M 1.67M
Cost of revenue 0.63M 2.05M -0.65M 0.76M 0.00M
Total other income expense net 1.11M -22.22M 11.94M -1.30M -0.63M
Discontinued operations - - -3.42M -3.42M -3.42M
Net income from continuing ops -3.27M -32.28M -8.24M -8.13M -2.30M
Net income applicable to common shares - - -11.66M -8.13M -2.30M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 7.91M 8.84M 39.00M 8.05M 4.27M
Intangible assets 0.02M 3.80M 22.21M 0.26M 0.32M
Other current assets 0.39M 0.14M 0.81M 484886.00M 0.11M
Total liab 3.64M 12.67M 12.10M 10.25M 9.31M
Total stockholder equity 4.28M -3.83M 26.90M -2.20M -5.03M
Other current liab 0.30M 2.66M 1.06M 8268428.00M -
Common stock 63.32M 51.02M 49.43M 7.26M 0.00M
Capital stock 63.32M 51.02M 49.43M 7.26M 0.00M
Retained earnings -57.46M -53.36M -21.09M -13.29M -5.16M
Other assets - - 0.48M - -
Cash 3.84M 0.09M 0.23M 3.50M 0.01M
Total current liabilities 3.64M 10.17M 9.35M 8.27M 2.73M
Current deferred revenue - - - -8268428.00M -
Net debt -3.49M 3.90M 3.67M 6.07M 9.11M
Short term debt 0.35M 1.50M 1.15M 7.59M 2.55M
Short long term debt 0.35M 1.37M 0.94M 7.15M 2.26M
Short long term debt total 0.35M 4.00M 3.90M 9.57M 9.12M
Other stockholder equity - - -1.45M 11092467.00M 0.13M
Property plant equipment - - 12.48M 3.81M 3.83M
Total current assets 5.06M 1.81M 3.82M 3.98M 0.13M
Net tangible assets - - 4.69M -2.46M -5.35M
Short term investments - 0.00M 0.26M - -
Net receivables 0.82M 0.28M 1.24M 0.24M 0.00M
Long term debt - 2.50M 2.63M - 3.98M
Inventory 0.00M 1.29M 1.06M -484885.76M 0.00M
Accounts payable 2.98M 6.01M 7.14M 0.68M 0.18M
Accumulated other comprehensive income -1.58M -1.49M -1.45M 3.84M 0.13M
Non currrent assets other 0.50M 0.59M 0.48M - -
Non current assets total 2.86M 7.03M 35.18M 4.07M 4.15M
Capital lease obligations 0.00M 0.14M 0.33M 2.42M 2.88M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -1.02M 0.02M -4.22M -0.58M -0.43M
Change to liabilities - - 2.92M 0.00M 0.14M
Total cashflows from investing activities -1.02M 0.02M -4.22M -0.58M -0.43M
Net borrowings -0.34M -0.08M -0.79M 6.18M 1.03M
Total cash from financing activities 8.99M 1.49M 14.14M 11.24M 1.03M
Change to operating activities - - -0.64M 0.37M -0.11M
Net income -4.10M -32.28M -11.66M -8.13M -2.30M
Change in cash 3.75M -0.16M -3.24M 3.48M -0.81M
Begin period cash flow 0.09M 0.26M 3.50M 0.01M 0.82M
End period cash flow 3.84M 0.09M 0.26M 3.50M 0.01M
Total cash from operating activities -3.98M -1.50M -11.47M -6.56M -1.35M
Issuance of capital stock 10.75M 0.00M 14.93M 5.05M 0.00M
Depreciation 0.14M 4.28M 3.76M 0.31M 0.25M
Other cashflows from investing activities -0.37M 0.03M -0.74M -0.74M 0.01M
Change to inventory 0.37M 0.48M 0.50M -0.71M -0.00M
Change to account receivables -0.25M 0.97M -0.59M -0.24M -0.24M
Other cashflows from financing activities -1.43M 1.57M 0.50M 6.68M 1.17M
Change to netincome - - -5.76M 1.85M 0.67M
Capital expenditures 2.10M 0.00M 0.31M 0.58M 0.44M
Change in working capital -0.95M 3.15M 2.18M -0.59M 0.03M
Stock based compensation - 1.25M 0.56M - -
Other non cash items 0.92M 23.34M -6.32M 1.85M 0.67M
Free cash flow -6.08M -1.50M -11.78M -7.13M -1.79M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AKAN
Akanda Corp		 -0.03
3.46%		 0.81 - - 2.08 0.55 0.44 -0.80
MKKGY
Merck KGaA ADR		 0.49
1.48%		 33.66 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -2.76
1.62%		 167.12 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR		 -0.05
0.24%		 20.97 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.		 0.50
1.19%		 42.35 - 10.66 0.01 1.16 2.94 23.11

Profile*

Akanda Corp

As of August 21, 2025, Akanda Corp. was acquired by First Towers & Fiber Corp., in a reverse merger transaction. Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products. The company was incorporated in 2021 and is headquartered in Toronto, Canada.

100 King St. W, Toronto, ON, Canada, M5X 1G5

416 862 7525

https://www.akandacorp.com

Name Title Year Born
Ms. Louisa Madiako Mojela B.Com., B.Comm Exec. Chairman 1956
Mr. Tejinder Virk CEO & Director 1982
Mr. Trevor W. Scott BAcc, BCom (Hons), CA(SA) CFO & Sec. 1980
Mr. Thomas Flow Chief Operating Officer 1977
Ms. Katharyn Field Interim CEO & Executive Director 1984
Dr. Gurcharn Deol B.A., M.A., Ph.D. Chief Financial Officer 1950
Mr. Thomas Flow Chief Operating Officer 1978
Ms. Katharyn Field Interim CEO & Executive Director 1983
Dr. Gurcharn Deol B.A., M.A., Ph.D. Chief Financial Officer 1968
Dr. Gurcharn Deol B.A., M.A., Ph.D. Chief Financial Officer 1969

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

GFR
CAD 10.93
+37.83%
MOON
CAD 4.86
+10.20%
HG
CAD 4.43
+9.93%
EPRX
CAD 10.57
+8.86%
NUAG
CAD 8.66
+8.79%
CSU
CAD 3257.60
-7.63%
DIV
CAD 3.85
-5.53%
TOI
CAD 99.00
-5.52%
BSX
CAD 0.82
-4.65%
LMN
CAD 26.79
-4.63%

Equity Sectors*

  • Basic Materials

    +3.88%

  • Communication Services

    -1.14%

  • Consumer Cyclical

    +0.75%

  • Consumer Defensive

    -0.36%

  • Energy

    +2.16%

  • Financial Services

    +1.33%

  • Healthcare

    +1.50%

  • Industrials

    +2.97%

  • Real Estate

    +0.41%

  • Technology

    +1.27%

  • Utilities

    +1.09%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…